This is likely to be a TGFβ specific effect and hence was not seen in previously published animal studies where genetic predisposition to scleroderma-like phenotype was not due to balanced TGFβ upregulation and where a reduction in pulmonary pressure was found in response to lanifibranor [14]. Here, TGFB1 is linked to scleroderma.